Yong Ji

Title: Yong Ji: Innovator in Pharmaceutical and Semiconductor Technologies

Introduction

Yong Ji is a notable inventor based in Jiangsu, China, recognized for his contributions to pharmaceutical and semiconductor technologies. With a total of 2 patents, he has made significant strides in developing innovative solutions that address critical health and technology challenges.

Latest Patents

Yong Ji's latest patents include an Oral GSNOR inhibitor and a pharmaceutical use thereof. This invention discloses a thiazolone derivative of N6022, which exhibits improved oral bioavailability and a longer half-life compared to N6022. In in-vitro experiments, the compound has shown the ability to enhance migration and tube formation in human umbilical vein endothelial cells affected by high glucose levels. Furthermore, animal studies indicate that this compound can promote angiogenesis and blood flow recovery in ischemic limbs of diabetic mice, suggesting its potential for treating diabetic vascular complications.

Another significant patent is the fan-out wafer level multilayer wiring package structure. This innovative package structure comprises multiple semiconductor chips, a multilayer interposer, and a vertical interconnection interposer. The design allows for effective signal interconnection between the semiconductor chip and the multilayer interposer, facilitating I/O signal transfer. This advancement is crucial for enhancing the performance and efficiency of semiconductor devices.

Career Highlights

Yong Ji has worked with esteemed institutions such as Nanjing Medical University and the 58th Research Institute of China Electronics Technology Group Corporation. His experience in these organizations has contributed to his expertise in both medical and electronic fields.

Collaborations

Yong Ji has collaborated with notable colleagues, including Liping Xie and Shuang Zhao. Their joint efforts have likely fostered innovation and development in their respective projects.

Conclusion

Yong Ji's work exemplifies the intersection of pharmaceutical and semiconductor innovations. His patents reflect a commitment to advancing technology that can significantly impact health and industry. His contributions are a testament to the importance of innovation in addressing contemporary challenges.